Govt unveils plans to boost clinical trials sector

January 09, 2026 (MLN):  The government of Pakistan is taking major steps to accelerate the development of the country’s clinical trial sector, aims to position Pakistan as a regional hub for clinical research.

The meeting was chaired by Federal Minister for Health, Syed Mustafa Kamal, and attended by Chief Executive Officer of the Drug Regulatory Authority of Pakistan (DRAP), Chief Executive Officer of the National Institute of Health (NIH), Director General Health, and Mr. Babar Saeed, Director of the Clinical Trial Unit, along with other senior officials, according to a press release issued.

Addressing the meeting, Syed Mustafa Kamal highlighted Pakistan’s potential to become a preferred destination for clinical trials.

He noted that amendments are being introduced in the DRAP Bio-Study Rules to establish a regulatory framework that is transparent, efficient, internationally compliant, and time-bound.

The Minister said that measures are being taken to promote clinical trials, including the rapid rollout of a modern digital system to ensure all applications are processed online, improving efficiency, transparency, and ease of research.

It was also shared that a National Clinical Trials Summit will be held in Pakistan, bringing together national and international experts, institutions, stakeholders, Contract Research Organizations (CROs), and sponsors to explore collaboration and showcase Pakistan’s research capabilities.

Syed Mustafa Kamal reaffirmed the government’s commitment to facilitating the introduction of new technologies and innovative medicines in the local market, offering full support to international CROs and sponsors conducting clinical trials in the country.

He concluded that these initiatives will strengthen Pakistan’s global position in research and development, enhancing healthcare outcomes and economic growth.

Copyright Mettis Link News